<DOC>
	<DOC>NCT00334828</DOC>
	<brief_summary>The purpose of this study is to compare eritoran tetrasodium and placebo in patients with severe sepsis and to demonstrate a reduction of mortality from all causes.</brief_summary>
	<brief_title>ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>INCLUSION CRITERIA: Age &gt;= 18 years Confirmed earlyonset severe sepsis, defined as: oObjective evidence of infection likely to be caused by a bacterial or fungal pathogen oPresence of at least 3 of 4 systemic inflammatory response syndrome (SIRS) criteria oSepsisassociated organ dysfunction Baseline Acute Physiology and Chronic Health Evaluation II (Apache II) Score of 21 to 37 &lt; 12 hours between onset of the first qualifying organ dysfunction and expected administration of study drug A commitment to full patient support EXCLUSION CRITERIA: Pregnancy or breastfeeding Extensive (&gt;20% Body Surface Area) thirddegree burns Weight &gt; 150 kg at admission Patients whose death from sepsis is considered imminent Patients not expected to survive for at least 2 months due to a preexisting and uncorrectable medical condition, or those in a chronic vegetative state Patients with severe congestive heart failure Patients currently receiving immunosuppressive therapy such as cyclosporine, azathioprine, or cancer chemotherapy Patients with granulocyte counts &lt; 1000/mm^3 unless the decreased count is believed to be due to sepsis Patients that required cardiopulmonary resuscitation in the 4 weeks prior to evaluation for enrollment Human immunodeficiency virus (HIV)positive patients with CD4 count &lt;= 50/mm^3 within 4 weeks of enrollment, or endstage processes Patients with significant hepatic impairment, portal hypertension, or esophageal varices Patients who are expected to be treated with endotoxinremoval devices Patients with active cancer Patients receiving polymyxin B or colistin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Severe sepsis</keyword>
	<keyword>septic shock</keyword>
	<keyword>sepsis</keyword>
</DOC>